Related Experiment Video

Updated: Jun 12, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

[Dysfunction of coagulation processes in patients after acute coronary syndrome--therapeutic implications]

Agata Kaczmarzyk-Radka1, Lucyna Lenartowska, Jerzy Lewczuk

  • 1Oddzial Kardiologii z Pododzialem Intensywnego Nadzoru Kardiologicznego, Wojewódzki Szpital Specjalistyczny, Ośrodek Badawczo Rozwojowy we Wrocławiu. agatakaczmarzyk@yahoo.com

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|May 25, 2010
PubMed

Insights

Acute coronary syndrome (ACS) standard therapy includes antiplatelet drugs, but many patients still face major adverse cardiovascular events (MACE). This review explores how coagulation issues, not just drug resistance, contribute to MACE after ACS.

Area of Science:

  • Cardiology
  • Hematology
  • Thrombosis Research

Context:

  • Acute coronary syndrome (ACS) involves artery blockage by platelet-rich thrombi.
  • Standard ACS treatment includes reperfusion, anticoagulants, and antiplatelet therapy.
  • Despite optimal therapy, many ACS patients experience major adverse cardiovascular events (MACE).

Purpose:

  • To review the role of coagulation parameter dysfunction in ACS patients.
  • To investigate the link between coagulation abnormalities and MACE.
  • To highlight potential therapeutic targets beyond standard antiplatelet treatments.

Summary:

  • Platelet aggregation and adhesion are key in ACS pathogenesis.
  • Drug resistance and underestimated coagulation processes may explain treatment failures.
  • Dysfunctional coagulation parameters are linked to MACE in coronary artery disease patients.

Impact:

  • Identifies coagulation dysfunction as a critical factor in ACS outcomes.
  • Suggests exploring coagulation pathways for improved MACE prevention.
  • Informs future research on managing cardiovascular risk in ACS patients.

More Related Videos

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...